Qiao Ren
National University of Singapore
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Qiao Ren.
Chemistry: A European Journal | 2010
Yaojun Gao; Qiao Ren; Lei Wang; Jian Wang
The development of asymmetric methods for the preparation of functionalized coumarins has been of long-standing interest to organic chemists. As a result of their broad applications in organic synthesis they are widely distributed in a vast array of bioactive molecules. Warfarin (see below) has been discovered as an anticoagulant, inhibiting Vitamin K epoxide reductase and thereby decreasing blood coagulation by preventing the vitamin K dependent synthesis of bloodclotting proteins. Bromadiolone is a second-generation 4hydroxycoumarin derivative, called as a “super-warfarin” for its added potency and tendency to accumulate in the liver of the poisoned organism. It was effective against the populations that had become resistant to the first-generation anticoagulants. Phenprocoumon is another anticoagulant drug
Chemistry: A European Journal | 2011
Qiao Ren; Woon-Yew Siau; Zhiyun Du; Kun Zhang; Jian Wang
The concept of a “privileged medicinal scaffold” has emerged as one of the most guiding principles in the process of drug discovery. The privileged scaffold commonly consists of a rigid hetero-ring system that assigns a well-defined orientation of appended functionalities for target recognition. In the light of this, the accessibility of convenient methods for the diversification of privileged scaffold functionalities impacts on the success in seeking potential drugs. Undoubtedly, the discovery of novel synthetic methodologies to facilitate the preparation of compound libraries is a pivotal focal point in modern medicinal chemistry. Chromene, as one of the privileged scaffolds, often appears as an important structural component in both biologically active and natural compounds. It has widely appeared in natural alkaloids, tocopherols, flavonoids, and anthocyanins. Moreover, in recent years functionalized chromenes have played an ever-increasing role in the field of synthetic and medicinal chemistry. Among the diverse chromene systems, 2-amino-4H-chromenes are particularly privileged medicinal scaffolds for the generation of small-moleculebased ligands with highly pronounced spasmolytic, diuretic, anticoagulant, and antianaphylactic activities. In particular, the current interest in 2-amino-4H-chromene derivatives with a nitrile functionality arises from their potential application in the treatment of human inflammatory tumor necrosis factor (TNF)a-mediated diseases, such as rheumatoid and psoriatic arthritis. The corresponding cyano-functionalized benzopyranopyridine (inhibitor of MK-2) originating from the 2-amino-4Hchromene scaffold was found to inhibit mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK-2) and suppress the expression of TNFa in U937 cells. In the case of cancer therapy, the tumor antagonist HA14-1 and a family of related alkyl (4H-chromen-4-yl)cyanoacetates are a new class of small molecules that exhibit a binding activity for the surface pocket of the cancer-implicated Bcl-2 protein and induce apoptosis or programmed cell death in follicular lymphoma B cells and leukemia HL-60 cells. The 2amino-3-cyano-4H-chromene MX58151, with a 3-bromo-4,5dimethoxyphenyl substituent at the 4-position, represents a promising class of proapoptotic small-molecule agents with multiple action modes against the breast cancer cell line T47D, the lung cancer cell line H1299, and the colorectal cancer cell line DLD-1. It induces caspase-mediated apoptosis in tumor cells and is about as potent as or slightly more potent than the commonly prescribed anticancer alkaloids Vinblastine and Paclitaxel in the caspase activation assay. Furthermore, compound MX58151 might have an advantage for the treatment of the drug-resistant cancers as it retains activity in tumor cells resistant towards current antimitotic agents, taxanes (including Taxol and Taxotere), and the Vinca alkaloids. The inhibition of tubuline polymerization and disruption of preformed endothelial cell capillary tubules constitute other significant activities of 2-amino-3cyano-4-aryl-4H-chromenes of type 3 that can place them in the row of effective anticancer therapeutics with an analogous mode of action. Most recently, another 2-amino-4aryl-4H-chromene compound (IRSP inhibitor) has been discovered as an insulin-regulated aminopeptidase inhibitor. In particular, this inhibitor is maybe useful in therapeutic application including enhancing memory and learning functions. In view of the significance of this framework, efficient syntheses of 2-amino-4H-chromenes are of great interest. [a] Q. Ren, W.-Y. Siau, Prof. Dr. J. Wang Department of Chemistry, National University of Singapore 3 Science Drive 3, Singapore 117543 Fax: (+65)6516-1691 E-mail : [email protected] [b] Prof. Dr. Z. Du, Prof. Dr. K. Zhang Faculty of Engineering and Light Industry Guang Dong University of Technology Guang Dong, 510006 (P.R. China) Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/chem.201100927.
Chemical Communications | 2014
Qiao Ren; Shaofa Sun; Jiayao Huang; Wenjun Li; Minghu Wu; Haibing Guo; Jian Wang
We disclose a novel efficient enantioselective organocatalytic cascade reaction for the preparation of δ-lactones in good to excellent yields (69-93%) and with high to excellent enantioselectivities (88-96% ee).
New Journal of Chemistry | 2015
Qiao Ren; Tao Gao; Wenjun Li; Li Wan; Yimin Hu; Yanhong Peng; Shaofa Sun; Liqiang Hu; Minghu Wu; Haibing Guo; Jian Wang
We disclose herein an efficient enantioselective organocatalytic Michael reaction between α,β-unsaturated ketones and malonic acid half thioesters (MAHTs). The reactions are catalyzed by a primary amine to generate Michael addition products in good to excellent yields (62–87%) with high to excellent enantioselectivities (80–98%).
Chemistry: A European Journal | 2010
Qiao Ren; Yaojun Gao; Jian Wang
Chemical Communications | 2010
Yaojun Gao; Qiao Ren; Hao Wu; Maoguo Li; Jian Wang
Chemical Communications | 2011
Yaojun Gao; Qiao Ren; Woon-Yew Siau; Jian Wang
Organic and Biomolecular Chemistry | 2011
Yaojun Gao; Qiao Ren; Swee-Meng Ang; Jian Wang
Organic and Biomolecular Chemistry | 2012
Zhiyun Du; Chenggang Zhou; Yaojun Gao; Qiao Ren; Kun Zhang; Hansong Cheng; Wei Wang; Jian Wang
ACS Catalysis | 2012
Qiao Ren; Jiayao Huang; Lei Wang; Wenjun Li; Hui Liu; Xuefeng Jiang; Jian Wang